Ledger.Open graph →
SEC Form D · filed August 14, 2025

SRT Therapeutics, Inc

Offering
$47.5M
Sold
$47.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Rolf Benirschke · San Diego, CADirectorBrian G. Feagan, M.D · San Diego, CADirectorEd Prunchunas · San Diego, CADirectorLauren Otsuki · SAN DIEGO, CAExec · DirectorMichael Walsh · Sacramento, CADirectorShierley Widjaja · SAN DIEGO, CADirectorRolf Benirschke · San Diego, CADirectorBrian G. Feagan, M.D · San Diego, CADirectorEd Prunchunas · San Diego, CADirectorMichael Walsh · Portland, ORDirectorLauren Otsuki · SAN DIEGO, CAExec · DirectorShierley Widjaja · SAN DIEGO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗